U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2006
190
Substance Class Protein
Created
by admin
on Mon Mar 31 21:15:01 GMT 2025
Edited
by admin
on Mon Mar 31 21:15:01 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
J2D279PEM5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GARDASIL COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Preferred Name English
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
Common Name English
L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN ADSORBED ON AMORPHOUS ALUMINIUM HYDROXYPHOSPHATE SULPHATE
Common Name English
GARDASIL 9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN J2D279PEM5 DEFINITION TYPE
Common Name English
GARDASIL-9 COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN J2D279PEM5 DEFINITION TYPE
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Common Name English
SILGARD COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Brand Name English
HUMAN PAPILLOMAVIRUS QUADRIVALENT (TYPES 6, 11, 16, AND 18) VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE, RECOMBINANT INJECTION, SUSPENSION COMPONENT HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
Common Name English
HUMAN PAPILLOMAVIRUS TYPE 18 CAPSID PROTEIN ANTIGEN, A
Common Name English
RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN
Common Name English
L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 18 VACCINE
Common Name English
Classification Tree Code System Code
EMA ASSESSMENT REPORTS GARDASIL (AUTHORIZED: CONDYLOMATA ACUMINATA)
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
NDF-RT N0000183891
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
WHO-ATC J07BM01
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
EMA ASSESSMENT REPORTS SILGARD (AUTHORIZED: CONDYLOMATA ACUMINATA)
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
WHO-ATC J07BM03
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
NCI_THESAURUS C75791
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
WHO-ATC J07BM02
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
Code System Code Type Description
FDA UNII
J2D279PEM5
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY
EVMPD
SUB22594
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY
NDF-RT
N0000170916
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY Vaccines, Inactivated [Chemical/Ingredient]
EVMPD
SUB25253
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY
DRUG BANK
DB10302
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY
NDF-RT
N0000183364
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY Actively Acquired Immunity [PE]
RXCUI
458451
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
ALTERNATIVE
NCI_THESAURUS
C77717
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY
DAILYMED
J2D279PEM5
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY
NDF-RT
N0000175336
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY Papillomavirus Vaccines [Chemical/Ingredient]
RXCUI
798266
Created by admin on Mon Mar 31 21:15:01 GMT 2025 , Edited by admin on Mon Mar 31 21:15:01 GMT 2025
PRIMARY
Related Record Type Details
HUMAN PAPILLOMAVIRUS SEROTYPE 18 WHOLE
TARGET ORGANISM->VACCINE ANTIGEN
Related Record Type Details
HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN ANTIGEN
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966